Walker Karen Marie

Kyverna Therapeutics, Inc. · Chief Technology Officer

Walker Karen Marie is listed in filings as Chief Technology Officer at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 17, 2025, including sale activity. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX). The current snapshot covers public activity from Apr 15, 2025 to Dec 17, 2025. Reported amounts are shown as $292.8K to $115.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.